| Sign In to gain access to subscriptions and/or personal tools. |
Childhood Mefloquine-Induced Mania and Psychosis: A Case ReportDepartment of Pediatrics, The Institute of Child Health, Kolkata, West Bengal, India, rajoothapa{at}yahoo.co.in
Department of Pediatrics, The Institute of Child Health, Kolkata, West Bengal, India Mefloquine, a commonly used oral antimalarial is occasionally associated with severe, neuropsychiatric adverse effects, especially in adults. Such events are extremely rare in children. The authors report on an 11-year-old, otherwise healthy girl from Eastern India, a malaria-endemic region, who developed mania and psychosis following intake of a therapeutic dose of mefloquine for Plasmodium falciparum malaria. She recovered satisfactorily with risperidone therapy. To our knowledge, there is only one documented instance of mefloquine-induced psychosis in the pediatric literature to date. Those caring for children need to realize that severe neuropsychiatric manifestations may be seen in the pediatric age group. A positive history of intake of the offending drug with careful exclusion of other etiologies usually clinches the diagnosis.
Key Words: mefloquine mania psychosis malaria
This version was published on August
1, 2009 Journal of Child Neurology, Vol. 24, No. 8,
1008-1009 (2009) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||